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Abstract Curcumin (diferuoylmethane) is a natural compound 
with anticareinogenic activities which is able to exert either 
proapoptotic or antiapoptotic effects in different cell types. This 
paper focuses on the sequence and extent of primary events 
induced by curcumin, in comparison with those occurring during 
dexamethasone-induced apoptosis in rat thymocytes. It also 
presents annexin VI-FITC as a new probe for studying 
membrane asymmetry. Curcumin readily penetrates into the 
cytoplasm, and is able to accumulate in membranous tructures 
such as plasma membrane, endoplasmic reticulum and nuclear 
envelope. Curcumin-treated cells exhibit typical features of 
apoptotic cell death, including shrinkage, transient phosphatid- 
ylserine exposure, increased membrane permeability and de- 
crease in mitochondrial membrane potential. However, nuclei 
morphology, DNA fragmentation, the extent and time-course of 
membrane changes are different from those observed during 
dexamethasone-induced apoptosis, suggesting that, despite many 
similarities, the mode of action and the events triggered by 
cnrcumin are different from those occurring during typical 
apoptosis. 
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ing either stimulation of this phenomenon in proliferating 
promyelocytic leukemia HL-60 cells [6], or its prevention in 
dexamethasone-treated rat thymocytes [5]. To explain this 
paradox, a broad spectrum of mechanisms have been pro- 
posed which include alterations in arachidonate metabolism 
[7,8], inhibition of protein kinase C [9], and redox regulation 
[10,Ill. 
In this paper, we analyzed the primary effects of the pres- 
ence of CUR in rat thymocytes, and compared the sequence 
and extent of CUR-evoked events with those occurring during 
the typical apoptotic program induced by dexamethasone 
(DEX). The fluorescence and lipophilic properties of CUR 
[12] provided the basis for the search of its cellular localiza- 
tion and for analyzing the local effects on the structure and 
function of cellular membranes. Plasma membrane asymmetry 
was studied by a new fluorescence probe, i.e. annexin VI (Anx 
VI), isolated from porcine liver and coupled with FITC. We 
could investigate other parameters uch as plasma membrane 
permeability, mitochondrial membrane potential, as well as 
other typical apoptotic features ,i.e. changes in cell volume, 
nucleus morphology and DNA fragmentation. 
2. Materials and methods 
1. Introduction 
Growing interest focuses on new antitumor strategies which 
involve the regulation of the cell death program [1]. Curcumin 
(CUR, 1,7-bis(4-hydroxy-3-methoxyphenyl)- 1,6-heptadiene- 
3,5-dione), the natural yellow dye from powdered rhizomes 
of Curcuma species, exhibits antiinflammatory, antimutagenic 
and anticarcinogenic activities [2,3]. CUR inhibits cell prolif- 
eration and can affect cell cycle [4,5]. Interestingly, it has been 
reported that CUR exerts opposite effects on apoptosis, show- 
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dexamethasone; FITC, fluorescein isothiocyanate; FSC, forward 
scatter; SSC, side scatter; Anx VI, annexin VI; JC-1, 5,5',6,6'- 
tetrachloro-l,l',3,3'-tetraethylbenzimidazolcarbocyanine iodide; PI, 
propidium iodide: PS, phosphatidylserine; A~,,~, mitochondrial 
membrane potential 
2.1. Cell cultures and drug exposure 
Thymocytes were isolated from 34  week old rats of a WKY/Ola/ 
Hsd/Lod barrier reared, inbred strain, as previously described [13]. 
Cells (5xl0~/ml) were incubated in RPMI 1640 medium supple- 
mented with 10% fetal calf serum, 100 IU penicillin, 100 lag/ml strep- 
tomycin, 2 mM L-glutamine in a humidified atmosphere of 5% CO2 in 
air at 37°C. 50 laM CUR (Sigma; 10 mM stock in methanol, pro- 
tected from light, stored at -20°C) was used in the presence or ab- 
sence of 10 7 M DEX (Sigma) 
2.2. Analysis of cell membrane asymmetry and permeability 
2.2.1. Purification of annexin VI fi'om porcine liver and FITC-Anx 
VI preparation. The fraction of Ca 2+-precipitable proteins from por- 
cine liver homogenate was purified according to [14] and stored at 1-2 
mg/ml in 20 mM Tris-HC1, pH 7.4, 1 mM EGTA at -20°C. The 
purity of Anx VI was analyzed by SDS-PAGE. FITC (fluorescein 
isothiocyanate isomer I, Sigma) coupling to Anx VI was performed 
as described [15]. Briefly, after dialysis against a FITC coupling buffer 
(50 mM sodium borate-NaOH, pH 9.0, 150 laM NaCI, 1 mM EDTA) 
Anx VI was mixed with FITC (1:2, mol/mol) and incubated for 2 h at 
37°C, The reaction was stopped by the addition of 100 mM glycine 
and the mixture was dialyzed against 50 mM Tris-HCl, pH 8.0, 80 
mM NaCI, 1 mM EDTA. The complex was purified using FPLC 
(Pharmacia) system with" MonoQ column (NaC1 gradient: 80~,00 
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mM at 1 ml/min) and analyzed for protein content and at 492 nm 
(FITC content, a=78000 tool ~ 1 cm ~). 
2.2.2. Double staining with FITC-Anx Vl+propidium iodide 
(PI). Annexins preferentially bind to negatively charged phospho- 
lipids such as phosphatidylserine (PS) [15]. We used a two-color flow 
cytometric approach with FITC-Anx VI/PI, which allows the identi- 
fication of three cell subpopulations on the FL-I/FL-2 dot plot: PS / 
PI-  (intact cells), PS~/PI (cells with lost asymmetry but preserved 
membrane integrity) and PS~/PI + (cells with compromised mem- 
brane). One million cells were washed with PBS and resuspended in
binding buffer (10 mM HEPES-NaOH, pH 7.4, 140 NaC1, 2.5 mM 
CaCI~). F1TC-Anx VI was added at a final concentration of 1 ~g/ml, 
and PI was simultaneously added (see below). After 10 min incubation 
in the dark at room temperature, cells were analyzed by flow cytom- 
etry. Considering that the natural fluorescence of CUR can slightly 
interfere with the emission of FITC and PI, we set control gates on 
the FL-1/FL-2 dot plot for CUR-treated and non-treated cells before 
labelling with FITC-Anx VI or PI. However, the amount of unspecific 
staining due to the natural fluorescence of CUR was always < 2% 
(data not shown). Cell volume changes were monitored concomitantly 
by analysis of forward scatter (FSC), considering the ability of the 
cells to exclude PI and expose PS. 
2.2.3. P1 exclusion test. Short incubation with PI, a charged cat- 
ionic dye (Sigma), results in selective labelling of cells with a defective 
transport system and lost structural integrity [16]. The assay distin- 
guishes on the FSC/FL-2 dot plot early apoptotic ells (PI '~in') and late 
apoptotic/necrotic (PIh~igl't) from control cells (PI-) independently of
DNA oligonucleosomal fragmentation. 2.5× 105 cells were washed 
and suspended in PBS. Thymocytes were stained supravitally with 
5 lug/ml PI in PBS for 10 rain in the dark at room temperature and 
subsequently analyzed by FACS. 
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2.3. Measurement q/' mitochondrial membrane potential d~,,, 
A~,. was measured by using the specific, fluorescent lipophilic cat- 
ion JC-1 (5,5',6,6'-tetrachloro-l,l',3,3'-tetraethylbenzimidazolcarbo- 
cyanine iodide, from Molecular Probes, Eugene, OR), as described 
[17 21]. JC-I exists in monomeric form (t,,,~=490 nm: ~.,,,= 
527 nm), selectively enters into mitochondria nd in the presence of 
a high A~., reversibly forms aggregates (~.,,~,, = 590 nm). Both the t, .... 
can be evaluated by most flow cytometers at the FL-I/FL-2 dot plot. 
Additional, control samples were always prepared treating cells with 
100 nM valinomycin, capable of collapsing A~.,, to test the decrease 
in JC-I red fluorescence, as already reported [17[. The fluorescence of 
curcumin (~.~,~ =420 nm: t,.,, =495) did not interfere with the detec- 
tion of JC-I monomers or aggregates (data not shown). 2.5x10 '~ 
thymocytes were incubated with 2.5 lag/ml JC-1 in the dark for 
10 min at room temperature in complete medium. Then, cells were 
washed twice in PBS, resuspended in 400 ~1 PBS and analyzed by flow 
cytometry. 
2.4. Analysis ql' hypodiploid nuclei 
DNA content was analyzed in the nuclei by reduced fluorescence of
the classical DNA binding dye PI according to Nicoletti et al. [22]. 
Briefly, I x  10 ~ cells were washed in PBS and gently resuspended in
1 ml of 50 ~tg/ml PI in hypotonic solution (0.1% sodium citrate, 0.1% 
Triton X-100, Sigma) and incubated for at least 30 min prior to FACS 
measurement. The subdiploid DNA peak of apoptotic nuclei can be 
discriminated from the narrow peak of diploid DNA content on the 
red fluorescence histogram. Changes in forward and side scatter prop- 
erties (FSC/SSC) were also analyzed. 
2.5. Cott/oeal microscopy studies 
Thymocytes (5× 106/ml) were suspended in cold DMEM without 
phenol red and bicarbonate (Sigma) supplemented with 1.25% meth- 
V 
Fig. 1. Accumulation of curcumin in rat thymocytes. A: Typical image of curcumin-stained thymocytes 5 min following addition of the drug. 
B and C: An optical slice through the cell center - staining is present exclusively in the cytoplasm. Nucleus is not stained. D: An optical slice 
collected in an area of the thick layer of cytoplasm adjacent o the nucleus. 
E. Jaruga et al./FEBS Letters 433 (1998) 287-293 289 
FSC-Height (1) vs SSC-Height (2) 
CON 
. • . 
o 
i o ~o2 
tU  
o 
30' ' '"'"'101,FL2_~0eight, ,,,,,,, z , '"", 
CON 





FSC-Height (1) vs SSC-Height (2) 
I 
~.:! • ....:.  
. . " . . . "  




0 ca ' '" '" '101,FL2.~0eight,  ' " - ' ,  2' ' ' " "  
DEX 
)3 '  . . . . .  ~'0 4 
FSC-Height (1) vs SSC-Height (2) 
o 
. . •  • 
. % . ' . ••  • .  . 
• ." . . : ' . .  '.... ".i. : 
. : . .  -:.':" .. 
..: i': ." ". :..-.. " ~.. 
• ":::",': ". ,: " 
".: ..; ..,',.~,." . :  ... • 
:i: : ' 





o ' 101FL2 ~10e]ght 103 .... ~'04 







..... " :  : '_'i'o2" : : '" 3 . . . . . .  I-LZ rlelgnt 
Fig. 2. Changes in nuclear morphology and DNA content in rat thymocytes incubated for 20 h with curcumin (50 laM; CURl  and/or dexa- 
methasone (10 7 M; DEX), CON, control, non-treated cells. A: Changes in physical parameters (FSC and SSC) of nuclei. B: Sub-G~ fraction 
in thymocyte nuclei. Data are representative of three experiments. 
ylcellulose (Sigma). pH was adjusted to 7.4 using HEPES. Curcumin 
was added to a final concentration of 50 laM and the cell suspension 
was placed in a microincubator (Life Science Resources, Cambridge). 
Cells were maintained on a microscope stage at 37°C throughout the 
experiment. Images of curcumin fluorescence were recorded using a 
Bio-Rad MRC1024 confocal microscope, equipped with a 100 mW Ar 
ion laser (ITL). The 457 nm line was used for excitation, fluorescence 
was collected in the region of 540 + _ 15 nm. Integrity of plasma mem- 
branes was tested by exclusion of PI (5 pg/ml in PBS). Green and red 
autofluorescence of thymocytes was negligible under the conditions of 
the experiment. 
2.6. Statistical analysis 
The data are presented as the means + S.D. of at least three separate 
experiments. The differences between means after the indicated treat- 
ments were analyzed using Fisher test (variance analysis)• Significan- 
ces of differences were calculated using Student's t-test. Means were 
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Fig. 3. Changes in FSC of thymocytes during 20 h of incubation 
with indicated additives. A: Immediate shrinkage of CUR-treated 
cells (50 pM, CUR 0 h, gray line), compared with non-treated cells 
(CON 0 h, shaded). Gated PS--/PI cells (black line) after CUR ad- 
dition are smaller than non-treated cells. B: Peak broadening of 
DEX-stimulated cells after 1 h (10 7 M, DEX 1 h, thin line), com- 
pared with DEX-treated cells at time 0 h (DEX 0 h, shaded). Gated 
PS+/PI - cells (black line) after 1 h of DEX stimulation are smaller 
than non-treated cells. C: Cell shrinkage after 20 h incubation with 
50 pM CUR coadministrated with 10 -7 M DEX (CUR/DEX 20 h, 
gray line) did not differ from apoptotic shrinkage (DEX 20 h, black 
line). CON 20 h (non-treated cells, shaded). Data are representative 
of three experiments. 
3. Results 
3. l. Subcellular localization of curcumin 
Confocal images of thymocytes incubated in the presence of 
curcumin revealed a rapid penetration of the drug into intact 
cells. Curcumin did not enter cell nuclei and appeared to 
accumulate in a cytoplasmic compartment. Probably due to 
its lipophilic characteristics, the drug seemed to partition ex- 
clusively into membranous structures uch as plasma mem- 
brane, endoplasmic reticulum and nuclear envelope (Fig. 11. 
Staining of intracellular structures was seen in the cells with 
intact plasma membranes (i.e. those excluding PI). Curcumin 
did not enter cell nuclei even in cells whose plasma membrane 
integrity was compromised (as demonstrated by their perme- 
ability to PI). This observation would suggest that curcumin is 
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able to spread through the lipid phase of membranous struc- 
tures inducing local changes there. 
3.2. Nucleus morphology and DNA content 
Exposure to CUR resulted in the appearance of nuclei with 
higher FSC and SSC compared to controls. The number of 
morphologically different nuclei ncreased with time, from 6 to 
20 h of incubation, regardless of DEX presence. However, the 
majority of nuclei preserved the same FSC/SSC properties of 
control samples (Fig. 2A, CUR; CURIDEX). No cells treated 
with CUR (CUR alone or CUR plus DEX) showed hypodi- 
ploid characteristic, while about 314 of DEX-stimulated thy- 
mocytes presented changes typical of apoptotic ells (Fig. 2B, 
CUR and CUR/DEX vs. DEX). As expected, in almost all 
nuclei DEX caused a decrease of FSC and an increase of SSC 
(Fig. 2A, DEX) due to nucleus fragmentation a d chromatin 
condensation, respectively. 
3.3. Cell volume changes 
Curcumin induced an immediate shrinkage of the cell pop- 
ulation, as was presented on a FSC histogram by a shift of the 
main peak to the left, comparing to non-treated cells (Fig. 3A, 
CUR 0 vs. CON). DEX coadministration did not significantly 
change this picture (not shown). CUR-treated cells with ex- 
posed PS (PI-PS +) were a part of the shifted main peak while 
the cells with compromised plasma membrane (PI +) repre- 
sented a distant peak of smaller cells, localized to the left 
from the main peak (Fig. 3A, PS+/PI - vs. PI+). 
On the other hand, a DEX effect was noticed only after 60 
min showing firstly peak broadening and subsequently a shift 
of the main peak after 90 min (Fig. 3B, DEX 60 vs. DEX 0). 
Volume changes were accompanied by the appearance of PS 
positive cells representing the region between the control and 
PI ~ cells (Fig. 3B, PS+PI-). 
Thymocytes in the presence of curcurnin continued shrink- 
ing during next 20 h showing FSC values only slightly higher 
than that observed in apoptotic ells after DEX stimulation 
(Fig. 3C, CUR/DEX 20 h vs. DEX 20 h). 
3.4. Analysis of permeability to P1 and plasma membrane 
asymmetry 
CUR, regardless of DEX presence, caused an increase in 
membrane permeability to PI, showing a significantly in- 
creased fraction of the cells with compromised plasma mem- 
brane (PI I)'i~ht) compared to non-treated cells (Fig. 4A, CUR 
or CUR/DEX vs. CON, P< 0.05). However, the amount of 
PI ~''~ht cells after CUR coadministration did not exceed 7% 
during the first 2.5 h, while DEX alone made them 3% (Fig. 
4A, CUR/DEX vs. DEX, P < 0.05). 
The subpopulation of PI 'ti''~ thymocytes corresponds to the 
ceils with effective transport systems that prevent PI from 
reaching DNA despite a partly lost membrane integrity; These 
cells are commonly considered early apoptotic cells. Their 
number tended to increase only after DEX stimulation (Fig. 
4A, DEX). - 
We analyzed phosphatidylserine exposure using Anx VI in- 
stead of the commonly used Anx V. The relative mass of Anx 
VI is 68 kDa, while that of Anx V is 33-37 kDa; Anx VI has 
eight binding sites for PS, while Anx V has only four (re- 
viewed in [23,24]). This would make Anx V Ia  less sensitive 
probe in PS detection, but the stoichiometric 1:2 complex of 
Anx VI:FITC should compensate for the disadvantages men- 
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Fig. 4. Changes in plasma membrane permeability and asymmetry in thymocytes incubated for the indicated time at 37°C with dexamethasone 
(10 -7 M; DEX) and/or curcumin (50 ~tM; CUR); CON, control, non-treated cells. A and C: Supravital PI staining (PI, 5 lag/ml) distinguishes 
PI bright and PI di'' cells among PI positive cells (see Section 2). Percentages of PI l'~i~ht and PI 'tim cells in population are expressed as means + S.D. 
of five independent experiments and are significantly different at P< 0.05 for A: P£'~ight-CON vs. CUR, DEX vs. CUR/DEX (0-150 min); 
pIai'"-DEX vs. CUR/DEX (at 150 min), and for C: PIbrig~t-CON vs. DEX, CON vs. CUR; PI4~'-CON vs. DEX, DEX vs. CUR/DEX (after 
20 h). B and D: Double staining with Anx VI-FITC (1 lag/ml) and PI (1 ~tg/ml) distinguishes PS positive thymocytes among the cells excluding 
PI- (see Section 2). 0/,, ps+/Pi per PI- cells are presented as means of four separate xperiments and are significantly different at P< 0.05 for 
B: DEX vs. CUR/DEX (0, 30, 90, 150 min), CON vs. CUR (0, 30, 60 min), CON vs. DEX (90, 150 min) and for D: CON vs. DEX and 
DEX vs. CUR/DEX (after 20 h). 
tioned above. In any case, parallel experiments were per- 
formed with a commercial Anx V-FITC kit (Bender Med 
System, Vienna, Austria), and the results described below 
with Anx VI-F ITC were fully confirmed (not shown). It is 
worth pointing out that porcine liver, as a source of annexin 
VI isolation, gives the opportunity to lower the costs of PS 
analysis. PS exposure was analyzed in the cells with intact 
membranes (i.e. P I - )  after electronic exclusion of thymocytes 
which were PI + (PI ai'' and PiP'right). Curcumin induced an 
immediate increase in PS + cells either in thymocytes not 
treated with DEX or in DEX-treated ones (Fig. 4B, CUR 
and CUR/DEX vs. CON, P < 0,05). Such an extent of phos- 
pholipid scrambling was observed in DEX-stimulated cells 
only after 2.5 h (Fig. 4B, DEX vs. CON, P<0.05) .  During 
the next 30 min in the presence of CUR,  the amount of PS+/ 
PI cells dropped steeply and returned to control the value 
showing 9°/,, until 1.5 h (Fig. 4B, CUR = CON). Compared to 
CUR, DEX led to slow PS redistribution observed to be sig- 
nificantly higher (20%, DEX) than control (9%, CON) after 
1.5 h, at P < 0.05. 
Fig. 4C shows that after 20 h incubation with DEX, 57% of 
cells were PI positive (32% P1 bright, 25% pldin~). CUR coad- 
ministration significantly lowered that value to 33% (DEX vs. 
CUR/DEX,  P< 0.05) which was not significantly different 
from the 26% due to CUR alone. In non-treated cells, 19% 
were PI positive. 
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Fig. 5. Percentage of rat thymocytes with depolarized mitochondrial 
membrane, after incubation with curcumin (50 gM: CUR) and/or 
dexamethasone (10 7 M: DEX): CON, control, non-treated cells. 
Results are presented as means_+ S.D. of four independent experi- 
ments. Data are significantly different at P<0.05 at 4 h for CON 
vs. DEX, at 6 h for CON vs. DEX, DEX vs. CUR/DEX and after 
20 h for all indicated treatments, 
Prolonged DEX treatment led to PS exposure in 91% P1- 
cells, as compared to 36°/,, of non-treated cells (Fig. 4D, DEX 
vs. CON, P < 0.05). CUR coadministration significantly low- 
ered the value to 59% (Fig. 4D, DEX vs. CUR/DEX, 
P< 0.05), not significantly different from the 50% of CUR 
alone. 
3.5. Measurement of mitochondrial membrane potential (A 
m) 
Curcumin induced an immediate decrease in A~.l in about 
7% of the cells, regardless of DEX presence (Fig. 5, CUR or 
CUR/DEX). However, the number of cells with low A~.l did 
not exceed 13% during the next 6 h of CUR exposure in either 
DEX-treated or untreated cultures (Fig. 5, CUR; CUR/ 
DEX). According to previous results [19] DEX caused a de- 
crease in A~,, in about 30% of the thymocytes in about 6 h 
(Fig. 5, DEX). 
A more prolonged incubation showed that CUR protected 
50% of DEX-stimulated cells against A~,, collapse (Fig. 5, 
44% cells depolarized in CUR/DEX vs. 94% after DEX, 
P<0.05). However, CUR alone induced a significant mito- 
chondrial membrane depolarization i 40% of the cells, while 
non-treated cells showed only 16% (Fig. 5, CUR vs. CON, 
P < 0.05). 
4. Discussion 
The physicochemical properties of curcumin such as hydro- 
phobicity [25] predestine this molecule to easily pass the plas- 
ma membrane and spread throughout the lipid phase of mem- 
branous structures, i.e. endoplasmic reticulum (ER) and 
nuclear envelope. In this universal, non-specific way, curcu- 
rain could evoke structural and functional changes of cellular 
membranes simply partitioning into the lipid bilayer. Indeed, 
cells exposed to curcumin exhibited phosphatidylserine expo- 
sure, increased permeability of plasma membrane, decreased 
mitochondrial membrane potential and cell shrinkage. These 
features are commonly regarded as typically apoptotic. How- 
ever, looking into the sequence of DEX-induced or CUR- 
evoked events, we found several differences. Cell shrinking 
was an early change in DEX-stimulated apoptosis, occurring 
within 1 h. During the next 30 min shrinking was followed by 
the exposure of phosphatidylserine. Then, cells continued 
shrinking, showing increased plasma membrane permeability 
after 2.5 h. Transport efficacy and plasma membrane integrity 
were still preserved there, thus preventing the entrance into 
the nucleus of a dye such as PI. Decrease in A~,. was noticed 
only after 4-6 h of incubation, and was predated by DNA 
fragmentation, which was evident 2 h earlier on agarose gel, 
and accompanied by the cytofluorimetric appearance of a hy- 
podiploid peak (not shown), which is in agreement with pre- 
vious observations [5,19]. On the other hand, curcumin caused 
cell shrinkage, PS exposure, increased permeability and Atg,,, 
collapse immediately after its addition and the extent of these 
changes during prolonged incubation was significantly lower 
than after DEX stimulation. In addition, nuclear morphology, 
lack of the hypodiploic fraction and of DNA fragmentation 
(not shown) suggested rather a protective ffect of curcumin 
on DEX-treated rat thymocytes. 
Loss of membrane integrity was observed in the presence of 
curcumin very early, which is in striking contrast to what 
occurs during the apoptotic program. In fact, rupture of plas- 
ma membrane usually occurs later, after the morphological 
changes in the nucleus and DNA fragmentation [26]. We 
could exclude the possibility of a necrotic type of cell death 
since microscopic examinations and flow cytometry analysis 
of cell morphology did not show uncontrolled swelling. We 
observed rather shrinking and protection against cell rupture 
(see also [5]). It was reported that lymphocytes, once stimu- 
lated to shrink, cannot reverse that process by regulatory 
volume increase and activate the apoptotic program ending 
with DNA fragmentation [27]. Although curcumin exposure 
resulted in a loss of cell volume, in contrast, there was no 
subdiploid peak or DNA laddering (see also [5]), which sug- 
gests distinct pathways leading to cell shrinkage or DNA 
fragmentation. Moreover, the inhibition of DNA endonu- 
clease(s) observed in thymocytes seems to be indirect, since 
it is possible to induce DNA fragmentation i  the presence of 
curcumin, as observed elsewhere [6]. 
We assume that PI uptake is the expression of a non-spe- 
cific effect of the drug on the membrane structure. CUR par- 
titioning into lipid bilayer could result in alterations of lipid 
packing or/and transbilayer motion of the lipids thus increas- 
ing the basal permeability of the plasma membrane. In eryth- 
rocytes, curcumin expanded the membrane (echinocytosis) 
and decreased the order of membrane lipids by inducing their 
rearrangement probably due to the appearance of non-bilayer 
structures during drug penetration (Jaruga et al., Exp. Cell 
Res., accepted). In thymocytes, adding curcumin also resulted 
in transient pbosphatidylserine scrambling. Both membranous 
events, loss of asymmetry and increase of permeability, took 
place concomitantly and earlier than after DEX stimulation, 
suggesting the presence of an apoptosis-independent ffect. 
Interestingly, the recovery of original PS location in such a 
short time could be possible only due to active aminophos- 
pholipid translocase, which was reported to be inhibited in the 
course of apoptosis [28 31]. Our observations in erythrocytes 
showed directly that curcumin did not affect flippase activity 
(Jaruga et al., Exp. Cell Res., accepted). 
Curcumin was found to collapse A~,,L immediately after its 
addition to cell cultures. Taking account of the lipophilic 
character of curcumin and its ability to dissociate protons 
(pK values for the three acid protons: 7.8, 8.5 and 9.0, respec- 
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tively [32]) curcumin might be suspected to increase perme- 
ability for protons and interfere with the energy-coupling sys- 
tem in the mitochondria, regardless of apoptosis induction. 
One could speculate that as a consequence of energy dissipa- 
tion in mitochondria, cells are suffering from an increased 
level of reactive oxygen species. It was reported that coadmi- 
nistration of antioxidants like superoxide dismutase or cata- 
lase prevents curcumin-induced apoptosis in human leukemia 
cells [6]. On the other hand, curcumin is a known antioxidant 
and scavenger of free radicals [33]. It also increases the level of 
glutathione thus preventing thiol depletion occurring typically 
during apoptosis [34]. In view of this controversy, the role of 
curcumin in redox balance during apoptosis needs further 
study. 
The membranous changes evoked by curcumin do not seem 
to depend on activation of the apoptotic program, although 
they could alter several biochemical pathways. For example, 
curcumin might modulate enzymes activities by e.g. changing 
the access to phosphatidylserine. It is tempting to speculate 
that inhibition of protein kinase C (PKC) by curcumin [9] is 
due to such an effect. Interestingly, the size of domains con- 
sisting of PS, MARCKS peptide, substrate and DAG in- 
creased proportionally to the PS concentration thus accelerat- 
ing the PKC reaction [35]. Moreover, curcumin was found to 
inhibit PKC activity in a competitive way with regard to 
phosphatidy[serine [9]. 
Curcumin has attracted the attention of many scientists 
since it is considered a potent anticancer drug. Searching for 
possible explanations of the basic mechanisms underlying a 
broad spectrum of its biological effects, we investigated the 
perturbations of membrane structures and/or activities which 
resulted from the localization of curcumin. Curcumin was 
found to affect structure and functions of cellular membranes 
and mimic typical events occurring during apoptosis. How- 
ever, in striking contrast to what happens during apoptotic 
cell death, these events were immediate, partly reversible, and 
cells could recover in a relatively short time. 
Finally, from a methodological point of view, it is worth 
pointing out that reliable discrimination of apoptosis in the 
presence of membrane-disturbing compounds like curcumin 
requires an accurate analysis of the meaning of the effects 
which are linked to the physicochemical properties of the 
drug rather than to its biological activities. 
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